Skip to main content
. Author manuscript; available in PMC: 2023 Mar 28.
Published in final edited form as: Toxicol Appl Pharmacol. 2022 Sep 21;454:116252. doi: 10.1016/j.taap.2022.116252

Fig. 3.

Fig. 3.

Summary of molecular changes observed in target immune cells due to uranium exposure and potential health outcomes. Column one lists target immune cell categories including lymphocytes (T-cells, B-cells, and natural killer cells), leukocytes (all white blood cells) and peripheral blood mononuclear cells or PBMCs (T-cells, B-cells, natural killer cells and dendritic cells). Column two summarizes the effects reported for the target immune cells (references listed below each reported immune cell effect). Column three lists potential health outcomes that may arise due to reported effects on target immune cells.